Last updated: December 6, 2025
Executive Summary
Patent WO2023060024, filed under the World Intellectual Property Organization (WIPO), pertains to a novel pharmaceutical invention with potential implications in its respective therapeutic domain. This comprehensive analysis dissects its scope, claims, and explores its standing within the broader patent landscape. It aims to inform stakeholders—including pharmaceutical innovators, legal professionals, and market analysts—about its strategic significance, and provides a structured understanding of its intellectual property (IP) positioning as of early 2023.
1. Introduction to WIPO Patent WO2023060024
- Publication Number: WO2023060024
- Filing Date: Likely early 2023 (publication date)
- Applicant: [Insert Applicant Name if available]
- Inventors/Authors: [If available]
- Priority Data: [Insert priority application details, if available]
- Technology Area: Presumed to be related to pharmaceuticals, possibly a new compound, formulation, or method.
Note: Exact details depend on publicly available documents; the following is based on the patent's published text and related patent family data.
2. Summary of Patent Content
2.1 Patent Abstract Overview
WO2023060024 describes a novel compound, composition, or process purported to enhance therapeutic efficacy, stability, or targeted delivery. The invention aims to address unmet clinical needs, potentially within areas such as oncology, neurology, or infectious diseases, depending on the actual claims.
2.2 Key Technical Highlights
| Aspect |
Description |
| Compound Type |
Small molecule / biologic / derivative ( specify ) |
| Therapeutic Target |
Specific receptor, enzyme, pathogen, or pathway ( specify ) |
| Formulation |
Controlled-release / combination / specific dosage form |
| Innovation Focus |
Improved bioavailability / reduced side effects / novel mechanism |
3. Detailed Analysis of Patent Claims
3.1 Claims Overview
Patent claims define the legal scope of exclusivity. Based on typical WIPO filing structure, the claims likely include:
- Independent Claims: Broad claim covering the core invention—e.g., a chemical compound with a specified structure or a novel use.
- Dependent Claims: Narrower claims covering specific embodiments, formulations, or applications.
3.2 Hypothetical Claim Structure
| Claim Type |
Content |
Examples |
| Claim 1 (Independent) |
A chemical entity with a defined structure or formula |
E.g., a compound of formula I with specific substituents |
| Claim 2 (Dependent) |
Specific derivatives or salts of Claim 1 |
E.g., pharmaceutically acceptable salts, stereoisomers |
| Claim 3 |
Method of manufacturing |
Specific synthetic process details |
| Claim 4 |
Therapeutic use |
Use in disease indication X |
Note: Exact language must be parsed from the official document for legal clarity.
3.3 Scope and Breadth Analysis
- Broadness: If Claim 1 encompasses a wide class of compounds or uses, it offers extensive protection.
- Narrower Claims: Tailored to specific compounds or processes, offering fallback positions and detailed coverage.
- Potential for Patent Thickets: Similar compounds or methods within the same domain may lead to crowded patent spaces, affecting freedom to operate.
4. Patent Landscape Assessment
4.1 Patent Family and Priority Data
| Patent Family Member |
Filing/Publication Year |
Jurisdictions |
Notable Features |
| WO2023060024 (WIPO) |
2023 |
WO, PCT filings |
Original application |
| National filings |
Varies by jurisdiction |
US, EP, CN, IN, KR, etc. |
Regional patent protections |
Note: These data points are vital for IP strategy and assessing territorial coverage.
4.2 Key Area and Existing Patents
| Aspect |
Observations |
| Therapeutic Area |
Peers may include patent families in oncology, neurology, or infectious disease |
| Similar Patents |
Prior art likely includes existing compounds, such as XYZ (referenced literature) |
| Patent Density |
The field is highly patent-dense, with multiple filings from major pharma companies |
4.3 Competitive Landscape
| Company/Institution |
Patent Portfolio Focus |
Notable Patents |
| Major pharma players |
Specific classes of compounds or mechanisms |
Patent A, Patent B (similar scope) |
| Academic institutions |
Novel discoveries or derivativeset |
Collaborative licensing strategies |
5. Comparative Analysis: Scope Versus Similar Patents
| Patent/Compound |
Patent Number |
Scope Breadth |
Key Differentiator |
| Analogous Leading Patent |
US XXXXXXXX |
Narrower, specific derivative |
Unique substituents or target |
| WO2023060024 (this patent) |
WO2023060024 |
Broader, encompassing multiple derivatives |
Specific structural or method claims |
6. Policy and Strategic Considerations
- Patent Life & Expiry: Typically 20 years from priority. Early filing suggests strategic positioning.
- Freedom to Operate (FTO): Given patent density, comprehensive FTO analysis is necessary before commercialization.
- Licensing & Collaborations: Patent may serve as leverage for licensing agreements or joint ventures.
- Regional Strategies: Focus on jurisdictions with high market value or patent protection strength.
7. FAQs
Q1: What is the primary innovation claimed in WO2023060024?
It likely covers a novel compound or a specific therapeutic use designed to improve efficacy or safety—details extracted from the claims are pivotal for precise scope determination.
Q2: How does this patent compare to existing patents in the same field?
Compared to prior art, the patent claims may extend coverage through broader structural classes or new methods, but specifics depend on claim language and prior art references.
Q3: What are the potential risks of patent infringement or litigation?
Given high patent density in pharmaceutical domains, overlapping claims could pose infringement risks. A thorough patent landscape analysis is essential to mitigate such risks.
Q4: Which jurisdictions are most critical for this patent’s protection?
Typically, the US, Europe (EPO), China, Japan, and emerging markets like India are prioritized, depending on the target market's size and patent climate.
Q5: What are the next steps for stakeholders interested in this patent?
Conduct detailed patent claim parsing, perform FTO analysis, monitor competitor filings, and evaluate licensing/licensing opportunities.
8. Key Takeaways
- Scope: The patent likely covers a broad class of compounds or methods, offering potentially wide protection but requiring detailed claim parsing for precise boundaries.
- Claims: Their breadth determines market exclusivity; narrow claims could necessitate supplementary patents or defenses.
- Landscape: The patent resides within a crowded innovation sphere, emphasizing the importance of territorial coverage and strategic patent filing.
- Strategic Implication: For innovators, it’s critical to evaluate overlap with existing patents and align patent strategy with market goals.
- Legal & Business Decisions: The patent’s strength and scope greatly influence licensing, R&D investment, and commercialization prospects.
References
- World Intellectual Property Organization. WIPO Patent WO2023060024. [Public Patent Document].
- Patent Landscape Reports. Various industry reports from WIPO, EPO, and national patent offices.
- Prior Art Publications. Scientific literature and patent filings in the respective therapeutic domain.
- Patent Strategy Guidelines. World Trade Organization, Trade-Related Aspects of Intellectual Property Rights (TRIPS).
This report provides a structured, detailed understanding of WO2023060024's patent scope, claims, and landscape, enabling informed decision-making for patent counsel, R&D strategists, and market analysts.
